Pharming Group reports earnings for the first nine months of 2022
Pharming Group N.V. presents its preliminary, unaudited financial report for the first nine months ended September 30, 2022.
The Company held a presentation for analysts on October 27, 2022 at 13:30 CET/07:30 ET.
To launch the audio webcast recording of the call please click on this link.
Presentation slides and a transcript of the call can be downloaded below.
"We will continue focusing on our strategic objectives and the internal review of our pipeline as we look to bring the unserved rare disease patient the solutions they need."- Sijmen de Vries | Chief Executive Officer